Lisdexamfetamine dimesylate

« Back to Glossary Index

Lisdexamfetamine, sold under the brand name Vyvanse among others, is a stimulant medication that is mainly used to treat attention deficit hyperactivity disorder (ADHD) in people over the age of five as well as moderate-to-severe binge eating disorder in adults.

Lisdexamfetamine was approved for medical use in the United States in 2007. In 2019, it was the 79th most commonly prescribed medication in the United States, with more than 9 million prescriptions.

It has a high potential for substance abuse per the DEA.  It is a scheduled II controlled substance in the United States.

NDEWS Alert (March 1, 2023) – Online Mentions

What was found? The drug Vyvanse has seen consistently high activity in drug-related subreddits for the past three years. There has been a slight consistent, upward trend in mentions since late 2021.

How is Vyvanse being discussed? The illicit use of Vyvanse is primarily discussed online in two contexts: recreational use as a general mood enhancer and non-recreational use as a “study” or focus drug. Many commenters who have procured the drug illicitly mention that they only did so after trying to obtain a prescription through legitimate means. Commenters also mentioned “stacking” the drug with other stimulants such as 2-FMA and phenibut.

National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913

Copyright © 2024 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy

Log in with your credentials


Forgot your details?

Create Account